● Covered by 4 sources · 5 reportsMedium impact5 negative
Boston Scientific reports cyberattack disrupting global operations and order processing
Key points
- Cyberattack detected by Boston Scientific on August 25.
- Disrupted IT systems, network access, and business applications.
- Impacted processing and shipping of customer orders globally.
- Full system restoration timeline is currently unknown.
- Cyberattack confirmed in a federal regulatory filing on Wednesday.
- Company filed with the U.S. Securities and Exchange Commission.
- Boston Scientific is based in Massachusetts.
- Company makes medically implanted devices like pacemakers and defibrillators.
- Boston Scientific treats around 48 million patients a year.
- Cyberattack discovered on Tuesday.
- Company hired a cybersecurity firm to deal with the damage.
- Boston Scientific reported $5.4 billion in net sales during the second quarter of 2026.
- Cyberattack did not affect existing implantable cardiac rhythm management devices.
- Cyberattack disrupted new remote activations for some cardiac monitors.
- CrowdStrike is assisting with the investigation.
- No signs of malicious activity on networks since August 25.
- Breach appears limited to some on-premises systems.
- Company hopes to resume shipping some products partially this week.
Cyberattack Disrupts Boston Scientific Operations
Boston Scientific, a medical technology company, detected a cyberattack on August 25. The incident led to a network outage and affected access to certain operating systems and business applications. This disruption has impacted the company's ability to process and ship customer orders globally.
Operational Impact and Response
Following the detection of the intrusion, Boston Scientific activated its incident response procedures and engaged external cybersecurity experts to investigate and assist with containment. The company has stated that the timeline for a full restoration of all affected systems is not yet known. The ongoing disruption is expected to continue affecting the company's operations, including order fulfillment.
Company Profile and Market Significance
Boston Scientific is a major global manufacturer of medical devices, specializing in products for minimally invasive procedures such as stents, catheters, and pacemakers. With 59,000 employees, 13 manufacturing facilities, and a presence in 127 countries, the company reported over $20 billion in revenue in 2025. The disruption to such a large medical device supplier could have broader implications for healthcare providers and patients relying on its products.
Ongoing Investigation
The company's investigation into the cyberattack is ongoing to determine its nature, scope, and potential operational or financial consequences. Details regarding the type of attack, the perpetrator, initial access methods, or whether data was exposed or stolen have not been disclosed in the filing to the U.S. Securities and Exchange Commission (SEC).
Updates
- Cyberattack did not affect existing implantable cardiac rhythm management devices.
- Cyberattack disrupted new remote activations for some cardiac monitors.
- CrowdStrike is assisting with the investigation.
- No signs of malicious activity on networks since August 25.
- Breach appears limited to some on-premises systems.
- Company hopes to resume shipping some products partially this week.
- Cyberattack discovered on Tuesday.
- Company hired a cybersecurity firm to deal with the damage.
- Boston Scientific reported $5.4 billion in net sales during the second quarter of 2026.
- Cyberattack confirmed in a federal regulatory filing on Wednesday.
- Company filed with the U.S. Securities and Exchange Commission.
- Boston Scientific is based in Massachusetts.
- Company makes medically implanted devices like pacemakers and defibrillators.
- Boston Scientific treats around 48 million patients a year.
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
The daily brief
One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.
One email a day. Unsubscribe in one click, any time.
Today's brief
Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.
▶ Play today's brief
New every morning, and the back catalogue is archived by date.
How outlets covered it
Boston Scientific is still recovering from a cyberattack detected on August 25 that disrupted its global operations, including manufacturing, order processing, and shipping. The incident highlights the vulnerability of critical medical technology infrastructure to cyber threats, impacting product availability and remote device activations.
Medical technology company Boston Scientific detected a cyberattack on August 25 that disrupted its global operations, affecting IT systems and the ability to process and ship customer orders. The full scope and impact of the incident, including potential data breaches, are currently unknown.
Medical device company Boston Scientific experienced a cyberattack that has disrupted its business operations, including the ability to process and ship customer orders. The incident's financial impact and full restoration timeline are currently unknown, but investors have been told it could take weeks to restore systems.
Medical device manufacturer Boston Scientific is experiencing a "global disruption" to its operations due to a cyberattack, affecting its ability to ship and process orders. This incident highlights ongoing cybersecurity challenges within the health technology sector, following similar attacks on other medical device makers.
Medical technology company Boston Scientific experienced a cyberattack on August 25 that disrupted its IT systems, causing a network outage and affecting its ability to process and ship customer orders globally. The incident impacts a major medical device manufacturer, potentially affecting the supply chain for critical medical equipment worldwide.